Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets in
Abstract Background Multiple sclerosis (MS) is a complex chronic inflammatory and degenerative disorder of the central nervous system.Accelerated brain volume loss, or also termed atrophy, is currently emerging as a popular imaging marker of neurodegeneration in affected patients, but, unfortunately, can only be reliably interpreted at the time whe